These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 38351003)
1. Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway. Zhang Y; Tu S; Ji X; Wu J; Meng J; Gao J; Shao X; Shi S; Wang G; Qiu J; Zhang Z; Hua C; Zhang Z; Chen S; Zhang L; Zhu SJ Nat Commun; 2024 Feb; 15(1):1333. PubMed ID: 38351003 [TBL] [Abstract][Full Text] [Related]
2. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454 [TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R Front Immunol; 2022; 13():832263. PubMed ID: 35371054 [TBL] [Abstract][Full Text] [Related]
4. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities. Cheong JE; Sun L Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698 [TBL] [Abstract][Full Text] [Related]
5. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs. Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532 [TBL] [Abstract][Full Text] [Related]
6. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Salminen A Ageing Res Rev; 2022 Mar; 75():101573. PubMed ID: 35085834 [TBL] [Abstract][Full Text] [Related]
7. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice. Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K Toxicology; 2020 May; 438():152458. PubMed ID: 32289347 [TBL] [Abstract][Full Text] [Related]
8. Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota. Alvarado DM; Chen B; Iticovici M; Thaker AI; Dai N; VanDussen KL; Shaikh N; Lim CK; Guillemin GJ; Tarr PI; Ciorba MA Gastroenterology; 2019 Oct; 157(4):1093-1108.e11. PubMed ID: 31325428 [TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Nguyen NT; Kimura A; Nakahama T; Chinen I; Masuda K; Nohara K; Fujii-Kuriyama Y; Kishimoto T Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19961-6. PubMed ID: 21041655 [TBL] [Abstract][Full Text] [Related]
10. Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults. Riazati N; Kable ME; Newman JW; Adkins Y; Freytag T; Jiang X; Stephensen CB Front Immunol; 2022; 13():917966. PubMed ID: 36248784 [TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase (IDO1) - Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease? Gonçalves M; Rodrigues-Santos P; Januário C; Cosentino M; Pereira FC Int Immunopharmacol; 2024 May; 133():112062. PubMed ID: 38652967 [TBL] [Abstract][Full Text] [Related]
12. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway. Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044 [TBL] [Abstract][Full Text] [Related]